Sonavex, Inc., a startup company originally formed in the Center for Bioengineering Innovation and Design at Johns Hopkins, received $3 million in funding, including $2.2 million from closing its Series A round. Investors include Grey Sky Venture Partners, CRCM Venture Capital, TEDCO, and the Abell Foundation.

The medical device company is dedicated to improving surgical patient outcomes with point-of-care imaging technologies. Sonavex plans to use the funds to help commercialize its EchoSure technology for detecting blood clots in surgical patients, as well as the development of its pipeline perioperative ultrasound solutions.

“This represents an exciting time for the company,” stated David Narrow, CEO of Sonavex and CBID alumnus. “Our traction has enabled Sonavex to not only raise capital to accomplish critical milestones, but also attract essential talent to support the company’s growth. Recent developments in our product pipeline has motivated us to increase the size of the round with a second tranche of $1.3 million.”

Get the full story from Sonavex.